Diabetes Focused Alinea Pharmaceuticals Inks $45 Million Series A 
10/19/2005 5:13:20 PM

10/11/2005. Alinea Pharmaceuticals Inc., a newly formed clinical stage start-up focused on the treatment of diabetes and metabolic disorders, has secured a $45 million Series A round, according to MPM Capital Venture Partner Todd Foley, a director at the company.